BDNF and Menkes disease: We hope to eventually establish a system that more accurately predicts antidepressant responsiveness in MD patients using not only serum BDNF data, but also technologies such as genomics, epigenomics, transcriptomics, proteomics, metabolomics, and connectomes [79].